For years, the marijuana industry has been involved in a kind of arms race toward creating super-potent cannabis products. Looking to provide veteran consumers enhanced highs and more bang for the buck, manufacturers over the past few years have gone full throttle to produce cannabis offerings with greater levels of THC (the psychoactive component in weed that gets users high). But that trend looks to be ebbing, in some respects, as an increasing amount of marijuana retailers across North America position themselves toward lower-dose creations that speak to an expanding mainstream audience.